Brachioplasty Market Report 2024

The brachioplasty market size has grown strongly in recent years. It will grow from $1.28 billion in 2023 to $1.39 billion in 2024 at a compound annual growth rate (CAGR) of 8.4%. The growth during the historic period can be attributed to several factors, the increasing prevalence of obesity-related conditions, rising demand for cosmetic procedures, advancements in surgical technology, growing awareness and acceptance of aesthetic surgeries, improvements in healthcare infrastructure, an expansion in disposable incomes, and an aging population seeking anti-aging treatments.

The brachioplasty market size is expected to see strong growth in the next few years. It will grow to $1.93 billion in 2028 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to the expansion of medical tourism in cosmetic surgery, the integration of robotics and AI into surgical procedures, regulatory approvals for new surgical devices, a shift towards outpatient and ambulatory surgical centers, and increasing investments in research and development for novel treatment options. Major trends during this period include the use of 3D printing for personalized implants, growing demand for non-invasive and scarless procedures, the rise of telemedicine and virtual consultations for pre-surgical planning, the expansion of wearable technology for monitoring post-operative care, a focus on sustainability and eco-friendly surgical practices, and the integration of augmented reality for surgical simulations.

The rising prevalence of obesity is expected to boost the growth of the brachioplasty market. Obesity is a medical condition marked by an excessive accumulation of body fat, which poses various health risks. Modern lifestyles contribute to this condition, with high-calorie, low-nutrient foods and sedentary habits being prevalent. Urbanization, easy access to fast food, and reduced opportunities for physical activity exacerbate the issue. Brachioplasty procedures are used to address excess skin on the arms, often resulting from weight loss or aging, providing patients with improved aesthetic results while focusing on safety and recovery. For example, a report published by the Office for Health Improvement and Disparities in May 2023 indicated that from 2021 to 2022, 63.8% of adults aged 18 and older in England were estimated to be overweight or obese, up from 63.3% the previous year. Thus, the increasing prevalence of obesity is driving the brachioplasty market.

Companies in the brachioplasty market are emphasizing safety and advancements in minimally invasive techniques, such as aesthetic ultrasound technology, to improve patient outcomes and reduce recovery times. Aesthetic ultrasound technology uses energy-based treatments to address skin laxity on the upper arms, offering a non-surgical alternative to traditional brachioplasty. For instance, in December 2023, Sofwave Medical Ltd., an Israel-based aesthetic medical company, received Food and Drug Administration clearance for its SUPERB technology. This technology is designed to enhance the appearance of skin laxity on the upper arms using non-invasive ultrasound. The SUPERB platform addresses issues such as sagging or loose skin from aging, weight loss, or other factors, and improves skin appearance without the risks and recovery times associated with conventional surgery or laser treatments.

In April 2024, Ascend Plastic Surgery Partners, a US-based management services organization in plastic surgery and aesthetics, acquired Ponte Vedra Plastic Surgery for an undisclosed amount. This acquisition aims to enhance patient care standards and provide high-quality aesthetic services across the nation. The partnership extends Ascend's reach into Florida, adding six surgeons and six new locations, thereby improving their ability to deliver innovative and compassionate care. Ponte Vedra Plastic Surgery, a US-based practice, specializes in cosmetic and reconstructive surgery, including brachioplasty.

Major companies operating in the brachioplasty market are Medtronic plc, B. Braun Melsungen AG, Stryker Corporation, Hologic Inc., Aesculap Inc., InMode Ltd., Lumenis Ltd., Sisram Medical Ltd., Cutera Inc., BTL Industries Ltd., Venus Concept Inc., Syneron Candela, Sientra Inc., Alma Lasers Ltd., Fotona d.o.o., Sciton Inc., Zimmer MedizinSysteme GmbH, Canfield Scientific Inc., Solta Medical Inc., Cadogan Clinic, Coco Ruby Plastic Surgery, UK Aesthetic Ltd., Nazarian Plastic Surgery, Ellipse Technologies Ltd.

North America was the largest region in the brachioplasty market in 2023. The regions covered in the brachioplasty market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the brachioplasty market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Brachioplasty is a cosmetic surgical procedure designed to enhance the contour of the upper arms. It involves the removal of excess skin and fat to improve the appearance of the arms and is commonly sought by individuals who have undergone significant weight loss or are experiencing signs of aging. This procedure aims to create a more toned and youthful look. Typically performed by plastic surgeons, brachioplasty requires a recovery period to achieve the best results.

The primary types of brachioplasty include traditional brachioplasty, minimal incision brachioplasty, and extended brachioplasty. Traditional brachioplasty, or standard arm lift surgery, involves a long incision extending from the armpit to the elbow to remove excess skin and fat. This method is effective for patients with considerable skin sagging and delivers significant results. The procedures are categorized into surgical and non-surgical types, serving end-users such as hospitals and cosmetic surgery clinics.

The brachioplasty market research report is one of a series of new reports that provides brachioplasty market statistics, including brachioplasty industry global market size, regional shares, competitors with an brachioplasty market share, detailed brachioplasty market segments, market trends and opportunities, and any further data you may need to thrive in the brachioplasty industry. This brachioplasty market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The brachioplasty market consists of revenues earned by entities providing services such as upper arm contouring, excess skin and fat removal, post-surgical care, and consultations for aesthetic improvements. The market value includes the value of related goods sold by the service provider or included within the service offering. The brachioplasty market also includes sales of surgical instruments, compression garments, and post-operative care supplies. Values in this market are ‘factory gate’ values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.


This product will be delivered within 3-5 business days.